Displaying 10 out of 5 results

  1. FILE PHOTO: The Bayer AG logo sits on display at the headquarters in La Garenne-Colombes, near Paris

    Bayer buys BlueRock in US$600 million bet on stem cell therapies

    German drugmaker Bayer is paying up to US$600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up investment in ...
  2. A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California

    Gilead, Novartis cancer therapies losing patients to experimental treatments

    Unusually high numbers of U.S. lymphoma patients are choosing experimental treatments over expensive cell therapies sold by Gilead Sciences Inc ...
  3. New Content Item

    Medicare offers to partially raise payment for cancer CAR-Ts

  4. New Content Item

    First cancer gene therapy gets US go-ahead